Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-740-9 | CAS number: 162492-07-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From July 12, 2017 to July 20, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- The test substance is a complex UVCB with an undefined molecular weight and therefore the DPRA assay cannot be conducted. Therefore, an LLNA study – being the first choice animal method – was initiated. The pre-tests of this study demonstrated too high irritation up to dose levels of 1%. It is stated in the OECD 429 guideline that […Despite the advantages of the LLNA over TG 406, it should be recognised that there are certain limitations that may necessitate the use of TG 406 (13) (e.g. false negative findings in the LLNA with certain metals, false positive findings with certain skin irritants…]. Going any further down in dose levels to reach a non-irritant level is not any longer meaningful in view of risk assessment. Therefore, the GPMT (according to OECD Guideline 406) was selected as a more appropriate method for skin sensitization.
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Based on the guinea pig maximisation test was conducted
Test material
- Reference substance name:
- Hexamethylene diisocyanate, oligomers, reaction products with 3-methoxypropylamine
- EC Number:
- 500-740-9
- EC Name:
- Hexamethylene diisocyanate, oligomers, reaction products with 3-methoxypropylamine
- Cas Number:
- 162492-07-1
- Molecular formula:
- C38H69N9O9
- IUPAC Name:
- Hexamethylene diisocyanate, oligomers, reaction products with 3-methoxypropylamine
Constituent 1
- Specific details on test material used for the study:
- CAS No.: 162492-07-1; Lot No.: 1591ZG-101; EINECS No.: 500-740-9; Purity: >98 %; Appearance: homogeneous, white powder
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- olive oil
- Concentration / amount:
- Dose level: 12%
Injection 1/ 0.1 mL FCA 1:1 with water
Injection 2/ 0.1 mL test item formulated in vehicle
Injection 3/ 0.1 mL test item formulated in a 1:1 mixture FCA/water - Day(s)/duration:
- Day 0
- Route:
- epicutaneous, occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- Dose level: 50%
The test item (in the minimal irritating concentration) was spread over 2 x 4 cm piece of gauze to saturation. The patch was secured with an occlusive dressing for 48 h. - Day(s)/duration:
- Day 7
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- Dose level: 10%
The flanks of the treated and control animals were cleared of hair by shaving. Pieces of gauze saturated with the test item resp. vehicle were secured to the previously unexposed area of the animals for 24 h with the same type of occlusive bandage as for topical induction. - Day(s)/duration:
- Days 21 and 22
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 4
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- Well defined erythema was seen 24 h after removal of the patches in 2/5 animals of the positive control group, and slight erythema for the remaining 3/5 animals. This result represents skin sensitization reaction in 100 % of tested animals. Slight erythema was still visible 48 h after removal of the patches in 3/5 animals. Oedema was not observed in any of the animals.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- Induction / Intradermal Injection: 12 % Induction / Topical Application: 50 % Challenge / Topical Application: 10 %
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- Slight erythema
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- Induction / Intradermal Injection: 12 % Induction / Topical Application: 50 % Challenge / Topical Application: 10 %
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- Very slight erythema
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- Not applicable
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- No oedema or erythema was observed.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- Induction / Intradermal Injection: 0.3%; Induction / Topical Application: 100%; Challenge / Topical Application: 100%
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- Well defined erythema was observed in 2/5 animals 24 hours after removal of the patches. For the remaining 3/5 animals slight erythema was seen. This result represents skin sensitization reaction in 100 % tested animals.
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- Induction / Intradermal Injection: 0.3%; Induction / Topical Application: 100%; Challenge / Topical Application: 100%
- No. with + reactions:
- 3
- Total no. in group:
- 5
- Clinical observations:
- Slight erythema was still visible in 3/5 animals 48 hours after removal of the patches. No oedema was observed in animals.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the study conditions, the test substance was not sensitizing.
- Executive summary:
A study was conducted to determine the allergenic potential or sensitizing capacity of the test substance according to OECD 406 Guideline (guinea pig maximisation test), in compliance with GLP. Thirty-four guinea pig (Dunkin Hartley) females were used. The study was performed with 2 test groups: 1 negative control group (10 animals) and 1 treated group (20 animals). 4 additional animals were used in the pilot study to assess the irritation potency via intradermal and topical application, which was used to determine the test concentrations for induction and challenge phase. A parallel positive control group using α-Hexylcinnamaldehyde conducted on 5 animals was shared with a concurrent study and served as a reliability check. The animals were inspected daily during the study. All skin reactions and any unusual findings, including systemic reactions, results from induction and challenge procedures were observed and recorded. Individual weights of animals were determined shortly before the test substance was applied and at the end of the study. For the induction phase, the test substance was administrated in a concentration of 12 % for intradermal injection and 50 % for topical application. For the challenge phase, a concentration of 10 % was used. No clinical signs and no deaths in any of the groups were observed. The body weights of all animals increased during the study. No edema or erythema was observed in animals of control group (vehicle only). Slight erythema were observed in 5/20 animals of the treated group 24 hours after removal of the patches. This result represents skin sensitization reaction in 25 % of tested animals. Very slight erythema was observed in 3/20 animals 48 hours after removal of the patches. Oedema was not observed in any of the animals. Well defined erythema was seen 24 hours after removal of the patches in 2/5 animals of the positive control group, and slight erythema for the remaining 3/5 animals. This result represents skin sensitization reaction in 100 % of tested animals. Slight erythema was still visible 48 hours after removal of the patches in 3/5 animals. Oedema was not observed in any of the animals. Under the study conditions,according to the sensitization classification GHS and CLP the sensitization rate of the test substance is 25 %, thereforethe test substance is not sensitizing (Hozova, 2017).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.